XNZE
GXH
Market cap74mUSD
Nov 13, Last price
0.93NZD
Name
Green Cross Health Ltd
Chart & performance
P/E
6.56
P/S
0.25
EPS
0.14
Div yield, %
5.06%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
-0.55%
Revenues
545m
+3.96%
Net income
20m
+27.67%
CFO
53m
+0.65%
Dividend
Jun 04, 20260.055 NZD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres, and offers support services provided to its medical centres, as well as medical centres outside the company. It also provides back office and operational services to medical centres; and offers family healthcare services through GP, accident, and medical centres under The Doctors brand. Green Cross Health Limited was incorporated in 1999 and is based in Auckland, New Zealand.
Key people
Rachael Newfield
Group Chief Executive Officer · since 2019
Kalpana Goundar
Chief Financial Officer · since 2023
Androulla Kotrotsos
General Manager - Community Health · since 2021
Wayne Woolrich
General Manager - Medical
John Andrew Bagnall
Non-Executive Director · since 2009
John Bolland
Non-Executive Director · since 2008
Craig Brockliss
Non-Executive Director · since 2022
Peter Merton
Non-Executive Director · since 2019
Independent Chairman of the Board · since 2019
Kenneth Orr
Independent Director · since 2012
Independent Director · since 2017
Catherine Treneman
Independent Non-Executive Director · since 2025
Valuation
Title NZD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||